IIPLA Newsroom

IIPLA News

Daily reporting, analysis, and legal-market coverage across patents, trademarks, copyright, licensing, disputes, and policy.

News Archive

Latest IP news

Filtered news

News results

555 articles matching your filters, newest first.

Moderna Settlement Caps Covid-19 Vaccine Patent Liability at $2.25 Billion, Sets Stage for Federal Circuit Appeal on Government-Contractor Immunity
PatentsUSA

Moderna Settlement Caps Covid-19 Vaccine Patent Liability at $2.25 Billion, Sets Stage for Federal Circuit Appeal on Government-Contractor Immunity

Moderna agrees to pay $950 million upfront and up to $1.3 billion more contingent on appeal outcome in dispute over lipid nanoparticle technology, preserving key legal question on…

Moderna Inc. has reached a landmark settlement with Arbutus Biopharma and Genevant Sciences over patent infringement claims related to lipid-nanoparticle technology used in its Covid-19 vaccine. The agreement limits Moderna’s total liability to $2.25 billion and includes a planned appeal to the Federal Circuit on the…

Thursday, March 5, 2026
IIPLA News Desk
Moderna Reaches Landmark $2.25 Billion Settlement with Genevant and Arbutus Over LNP Patent Dispute
PatentsUSA

Moderna Reaches Landmark $2.25 Billion Settlement with Genevant and Arbutus Over LNP Patent Dispute

Global agreement resolves U.S. and international litigation on lipid nanoparticle technology used in COVID-19 vaccines, averting imminent Delaware jury trial

Moderna, Genevant Sciences, and Arbutus Biopharma have finalized a global settlement addressing patent infringement claims related to lipid nanoparticle (LNP) delivery technology integral to Moderna’s COVID-19 vaccines. The deal includes an upfront payment of $950 million and potential additional payments up to $1.3 b…

Wednesday, March 4, 2026
IIPLA News Desk
Intellectual Keystone Technology Intensifies Lobbying Efforts Amid Congressional Patent Reform Push
PatentsUSA

Intellectual Keystone Technology Intensifies Lobbying Efforts Amid Congressional Patent Reform Push

The company targets patent eligibility, PTAB reform, and injunction rules as Congress advances bipartisan legislation to bolster IP protections in the display technology sector.

Intellectual Keystone Technology LLC has ramped up its lobbying activities in Washington, D.C., advocating for stronger patent protections aligned with ongoing congressional debates. With $2.16 million spent since early 2023, the company focuses on patent eligibility standards, PTAB reforms, and enforcement mechanisms…

Saturday, February 28, 2026
IIPLA News Desk
Florida Firm Alleges DHS and ICE Facial Recognition Systems Violate Five Patents
PatentsUSA

Florida Firm Alleges DHS and ICE Facial Recognition Systems Violate Five Patents

SecureNet Solutions Group files suit in US Court of Federal Claims over biometric and video analysis technologies used in immigration enforcement and protest monitoring

SecureNet Solutions Group LLC has initiated a federal lawsuit accusing the Department of Homeland Security, Immigration and Customs Enforcement, and Customs and Border Patrol of infringing five patents related to video data analysis and biometric systems. The complaint highlights the use of facial recognition, license…

Friday, February 27, 2026
IIPLA News Desk
Genprex Secures Key Japanese and European Patents for REQORSA Gene Therapy Combined with Immunotherapies in Cancer Treatment
PatentsGlobal

Genprex Secures Key Japanese and European Patents for REQORSA Gene Therapy Combined with Immunotherapies in Cancer Treatment

Patents bolster Genprex’s global IP portfolio, supporting ongoing Acclaim-3 clinical trial for small cell lung cancer with PD-L1 and PD-1 antibody combinations

Genprex, Inc. has obtained favorable patent grants from the Japanese Patent Office and European Patent Office covering the use of its REQORSA gene therapy in combination with PD-L1 and PD-1 antibodies to treat cancer. These patents reinforce Genprex’s intellectual property rights in major markets and underpin its Accl…

Monday, February 23, 2026
IIPLA News Desk
Supreme Court to Define Limits of Induced Patent Infringement Liability in Generic Drug Advertising
PatentsUSA

Supreme Court to Define Limits of Induced Patent Infringement Liability in Generic Drug Advertising

High Court to address whether generic drug makers’ broad marketing of ‘skinny label’ generics triggers induced infringement claims under patent law

The U.S. Supreme Court has granted certiorari in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. to clarify when advertising a generic drug as a ‘generic’ for a patented brand-name drug can lead to liability for induced patent infringement. The case focuses on ‘skinny label’ generics approved for non-patented us…

Thursday, February 12, 2026
IIPLA News Desk
Supreme Court to Address Induced Infringement Claims in Generic ‘Skinny Label’ Drug Marketing Dispute
PatentsUSA

Supreme Court to Address Induced Infringement Claims in Generic ‘Skinny Label’ Drug Marketing Dispute

Hikma Pharmaceuticals v. Amarin Pharma spotlights limits on generic drug promotion and patent infringement under Hatch-Waxman’s skinny labeling provisions

The U.S. Supreme Court has granted certiorari in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. to resolve whether generic drug makers’ marketing statements can support inducement claims of patent infringement when using skinny labels that omit patented uses. The case tests the boundaries of Hatch-Waxman’s Sect…

Wednesday, January 28, 2026
IIPLA News Desk
Novo Nordisk Faces Antitrust Lawsuit Over Alleged Monopoly on Victoza Diabetes Medication
PatentsUSA

Novo Nordisk Faces Antitrust Lawsuit Over Alleged Monopoly on Victoza Diabetes Medication

The pharmaceutical giant is accused of unlawfully monopolizing the market for its diabetes drug Victoza, prompting legal action in the United States.

Novo Nordisk has been sued for allegedly monopolizing the diabetes drug Victoza, with claims that the company engaged in anticompetitive practices to maintain exclusive control over the market. The lawsuit highlights concerns about market dominance and access to essential diabetes treatments.

Friday, January 23, 2026
IIPLA News Desk
Norton Rose Fulbright Survey Reveals Steady US Patent Disputes Amid Rising Concerns Over Third-Party Funding
TrademarksUSA

Norton Rose Fulbright Survey Reveals Steady US Patent Disputes Amid Rising Concerns Over Third-Party Funding

Corporate counsel anticipate stable patent litigation volumes in 2026 but warn of increased risks linked to third-party litigation financing

A recent survey by Norton Rose Fulbright of 400 US corporate counsel highlights a stabilization in patent dispute volumes while signaling potential risk escalation due to third-party funding in the coming year. The findings provide insight into evolving perceptions of intellectual property challenges across patents, t…

Friday, January 16, 2026
IIPLA News Desk
White & Case Strengthens Life Sciences IP Litigation Practice with New Team Addition
PatentsUSA

White & Case Strengthens Life Sciences IP Litigation Practice with New Team Addition

Global law firm White & Case LLP expands its intellectual property litigation capabilities by integrating a leading group of life sciences IP litigators.

White & Case LLP has bolstered its life sciences intellectual property litigation practice by adding a prominent team of litigators specializing in this sector. This strategic move enhances the firm’s capacity to handle complex patent disputes and IP enforcement within the life sciences industry, reinforcing its posit…

Thursday, January 15, 2026
IIPLA News Desk
Global Technology Licensing Market Projected to Reach $5.6 Billion by 2035 with Asia Pacific Leading
PatentsGlobal

Global Technology Licensing Market Projected to Reach $5.6 Billion by 2035 with Asia Pacific Leading

Robust growth driven by IoT expansion, digital economy rise, and strategic partnerships amid evolving IP commercialization landscape

The international technology licensing market, valued at over $2.1 billion in 2025, is forecasted to grow at a compound annual growth rate (CAGR) of 11.7% from 2026 to 2035, reaching $5.6 billion. Key drivers include the proliferation of IoT devices, increasing digital economy adoption, and government-backed innovatio…

Wednesday, December 31, 2025
IIPLA News Desk
McGuireWoods Partner Lucy Jewett Wheatley Recognized Again as Law360 Intellectual Property MVP
LitigationUSA

McGuireWoods Partner Lucy Jewett Wheatley Recognized Again as Law360 Intellectual Property MVP

Wheatley’s landmark trademark victories and high-profile litigation underscore her leadership in IP law

Lucy Jewett Wheatley, partner at McGuireWoods and co-leader of its Intellectual Property Practice Group, has been named a 2025 Intellectual Property MVP by Law360 for the second time. Her notable achievements include a pivotal trademark infringement trial victory for Pennsylvania State University and successful repres…

Monday, November 24, 2025
IIPLA News Desk
Eminem Challenges Australian Beachwear Brand Swim Shady Over Trademark Conflict
PatentsUSA

Eminem Challenges Australian Beachwear Brand Swim Shady Over Trademark Conflict

Rapper Eminem files petition with USPTO to cancel Swim Shady’s trademark, alleging brand name infringes on his Slim Shady identity

US rapper Eminem has initiated legal proceedings against Australian beachwear company Swim Shady, claiming the brand’s name infringes on his trademarked rap alias Slim Shady. The dispute centers on a trademark granted to Swim Shady in the US, which Eminem seeks to cancel through the US Patent and Trademark Office. The…

Tuesday, November 18, 2025
IIPLA News Desk
USPTO Operations Remain Stable Amid Government Shutdown, Federal Courts Face Funding Strains Impacting IP Litigation
LitigationGlobal

USPTO Operations Remain Stable Amid Government Shutdown, Federal Courts Face Funding Strains Impacting IP Litigation

Fee-funded USPTO continues full operations without disruption, while federal courts and ITC face funding challenges amid shutdown, affecting patent and trademark litigation timeli…

The United States Patent and Trademark Office (USPTO), uniquely funded by fees, remains fully operational during the ongoing government shutdown, with no observed decline in patent application activity. However, federal courts handling intellectual property litigation are experiencing funding shortages that may lead t…

Thursday, November 6, 2025
IIPLA News Desk
Federal Circuit Upholds Noninfringement Ruling for Fortress Iron in Fence Assembly Patent Dispute
PatentsUSA

Federal Circuit Upholds Noninfringement Ruling for Fortress Iron in Fence Assembly Patent Dispute

Foley & Lardner LLP secures affirmance of district court’s claim construction limiting patent terms to integral fastener-less connectors, defeating infringement allegations by Bar…

In a significant patent litigation victory, Foley & Lardner LLP successfully defended Fortress Iron LP and Fortress Fence Products LLC against infringement claims brought by Barrette Outdoor Living. The U.S. Court of Appeals for the Federal Circuit affirmed the Northern District of Texas’s claim construction, which co…

Thursday, November 6, 2025
IIPLA News Desk
Trump Seeks Supreme Court Approval to Remove U.S. Copyright Office Director
CopyrightUSA

Trump Seeks Supreme Court Approval to Remove U.S. Copyright Office Director

Former President Donald Trump petitions the Supreme Court to permit the dismissal of the Copyright Office head, challenging existing protections.

Donald Trump has filed a petition with the U.S. Supreme Court requesting authorization to fire the head of the U.S. Copyright Office. This move raises significant questions about the statutory protections afforded to the Copyright Office director and the limits of presidential authority over this position. The case co…

Monday, October 27, 2025
IIPLA News Desk
USPTO Director John Squires Reclaims Authority Over Patent Review Decisions from PTAB
LitigationUSA

USPTO Director John Squires Reclaims Authority Over Patent Review Decisions from PTAB

New USPTO leadership shifts control of inter partes and post-grant review determinations away from the Patent Trial and Appeal Board

John Squires, the newly appointed director of the U.S. Patent and Trademark Office, announced a significant policy change by reclaiming the agency's authority to decide whether to institute inter partes and post-grant reviews. This move transfers decision-making power from the Patent Trial and Appeal Board back to USP…

Friday, October 17, 2025
IIPLA News Desk
Disney and Universal Launch Pivotal Copyright Lawsuit Against Midjourney Over AI Image Training
LitigationUSA

Disney and Universal Launch Pivotal Copyright Lawsuit Against Midjourney Over AI Image Training

Major studios challenge generative AI's use of copyrighted characters, seeking injunctions and licensing safeguards in landmark federal case

On June 11, 2025, The Walt Disney Company and Universal Studios filed a federal lawsuit against AI firm Midjourney, accusing it of copyright infringement for training its image-generation models on proprietary characters without authorization. The case, filed in California, spotlights the legal tensions between creati…

Wednesday, October 8, 2025
IIPLA News Desk
Newsroom tools
Newsletters & Digests

Subscribe to IIPLA Newsroom

Get Top 5 IP News Today, weekly editorial roundups, and region-aware updates tailored to your practice.

Choose your regions
Choose your categories
By subscribing, you agree to receive IIPLA newsroom emails. You can update preferences or unsubscribe anytime.